Belite Bio (NASDAQ: BLTE) director discloses 400 ADS position

Rhea-AI Filing Summary

BELITE BIO, INC director Chen Xiao-Hui has filed an initial ownership report showing a modest personal stake in the company. The Form 3 indicates beneficial ownership of 400 American depositary shares as of March 18, 2026. Each American depositary share represents one ordinary share of Belite Bio, giving the director economic exposure to 400 ordinary shares. This filing does not reflect a new purchase or sale, but simply records existing holdings as the director becomes subject to insider reporting rules.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chen Xiao-Hui

(Last) (First) (Middle)

36F, NO.68, SEC.5

ZHONGXIAO E. RD., XINYI DIST

(Street)

TAIPEI CITY TAIWAN 110419

(City) (State) (Zip)

TAIWAN, PROVINCE OF CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
BELITE BIO, INC [ BLTE ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
American depositary share(1)	400	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the Issuer.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Xiao-Hui Chen	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Belite Bio (BLTE) director Chen Xiao-Hui report on this Form 3?

The filing shows director Chen Xiao-Hui beneficially owns 400 American depositary shares of Belite Bio. This is an initial ownership report, documenting existing holdings rather than a new stock purchase or sale transaction.

How many Belite Bio (BLTE) shares are reported on this Form 3?

The Form 3 reports beneficial ownership of 400 American depositary shares of Belite Bio. According to the disclosure, this is the director’s entire directly held position as of March 18, 2026, rather than a series of recent trades.

What does each Belite Bio (BLTE) American depositary share represent?

Each American depositary share represents one ordinary share of Belite Bio with a par value of US$0.0001. This means the director’s 400 ADS correspond economically to 400 underlying ordinary shares in the company.

Is Belite Bio (BLTE) director Chen Xiao-Hui buying or selling stock in this filing?

The filing does not show a buy or sell transaction. It is an initial ownership statement listing 400 American depositary shares already held, rather than reporting newly executed purchases, sales, or option exercises in Belite Bio stock.

Why is Belite Bio (BLTE) filing a Form 3 for director Chen Xiao-Hui?

Form 3 is required when someone becomes an insider, such as a director, and must disclose their current holdings. This filing records Chen Xiao-Hui’s 400 American depositary shares position upon becoming subject to ongoing insider reporting obligations.